Vaccine panel’s hepatitis B vote signals further turbulence for immunization policy, public trust12. Dezember 2025
Health Avanzanite Bioscience Secures €32M Series A Investment from MVM PartnersHealthradar22. November 2025 MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe,…
